drugset / Trial / NCT02932904

Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers

NCT02932904

Phase 4 Completed 361 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of vortioxetine (10 and 20 mg, once daily) versus paroxetine (20 mg, once daily) on sexual functioning in healthy participants after 5 weeks of double-blind treatment.

Timeline

Start
2016-11-21
Primary completion
2017-05-31
Completion
2017-06-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paroxetine Small molecule 20 mg Oral
Subject Vortioxetine Unknown 10 mg Oral
Subject Vortioxetine Unknown 20 mg Oral

Indications

No indication recorded.